Preferred Label : Branchiooculofacial syndrome;
Symbol : BOFS;
CISMeF acronym : BOFS;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Branchial clefts with characteristic facies, growth retardation, imperforate nasolacrimal
duct, and premature aging; Hemangiomatous branchial clefts-lip pseudocleft syndrome; Lip pseudocleft-hemangiomatous branchial cyst syndrome; Bof syndrome;
Description : Branchiooculofacial syndrome (BOFS) is characterized by branchial cleft sinus defects,
ocular anomalies such as microphthalmia and lacrimal duct obstruction, a dysmorphic
facial appearance including cleft or pseudocleft lip/palate, and autosomal dominant
inheritance. Although anomalies of the external and middle ear frequently cause conductive
hearing loss in BOFS, severe to profound sensorineural hearing loss due to inner ear
anomalies has rarely been reported (summary by Tekin et al., 2009). See also chromosome
6pter-p24 deletion syndrome (612582) for a similar phenotype, which lies telomeric
to the TFAP2A gene.;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the transcription factor AP2-alpha gene (TFAP2A, 107580.0001);
Prefixed ID : #113620;
Origin ID : 113620;
UMLS CUI : C0376524;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)